Pace® Life Sciences Terms & Conditions
Move Forward. Stay Ahead. As an extension to your team, you can count on us to move at your pace […]
Life Sciences
Pace® Life Sciences’ San German Site Receives Positive Inspection from FDA
Company commitment to quality excellence confirmed during FDA Inspection MINNEAPOLIS, MN – August 21, 2025– Pace® Life Sciences, a U.S.-based contract,
Pace® Life Sciences has been recognized by PharmaSource as a Top CDMO in the United States
The United States is global powerhouse in pharmaceutical contract development and manufacturing, home to some of the world’s most advanced
Pace® Life Sciences Debuts Enhanced cGMP Manufacturing Capabilities to Support Increasing Demand for Sterile Injectables
Company reopens state-of-the-art isolated vial filling line at Aseptic Fill-Finish Center of Excellence MINNEAPOLIS, MN – August 12, 2025 –
Pace® Life Sciences Achieves Fourth Consecutive Positive FDA Inspection, Reinforcing Quality Commitment
Research Triangle Park, NC site received a positive FDA Review, marking a milestone as all company Analytical Outsourcing sites have
Pace® Life Sciences Hosts Grand Opening of its Center of Excellence for Aseptic Fill-Finish Services in Salem, NH
July 16 open house highlights expanded sterile filling contract manufacturing capabilities for small and large molecules Minneapolis, MN – July
Pace® Life Sciences Announces Successful Pre-Approval Inspection from US FDA in Lebanon, NJ
Company confirms high standards for data integrity and quality systems MINNEAPOLIS, MN, May 20, 2025 Pace® Life Sciences, a U.S.-based full-service
Future role of Pace® Life Sciences in supporting biopharmaceutical development and manufacturing coast-to-coast – Dean Bornilla, Vice President.
With a growing network of locations across major US pharmaceutical hubs, Pace® aims to enhance customer experience through consistent quality
Pace® Life Sciences Awarded Bronze Medal from EcoVadis for Commitment to Sustainability
Company stands out in Ethics, Environment, and Labor and Human Rights focus areas for 2024 Minneapolis, MN – April 1,
Addressing the Complexity of Modern Therapeutics – Dr. Frank Tagliaferri, Pace® Life Sciences
The modern therapeutic landscape is defined by an ever-growing portfolio of complex drug products – from biologics and gene therapies